Good stuff MisterS - seems to me you are right
on it. And yes plenty of adjuvant work going on now
in ddRNAi - best route to commercialization.
The chronic pain programme is actually one now
too - includes to better utilize morphine at lower doses.
Pfizer will love it when the good data comes in, esp as it has Chinese connection
- Forums
- ASX - By Stock
- BLT
- combination treatments
combination treatments, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)